Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Performance-enhancing drugs: understanding the risks.

Caroline K Hatton1, Gary A Green2, Peter J Ambrose3

  • 1Sports Antidoping Science Consultant, PO Box 4795, Culver City, CA 90231, USA.

Physical Medicine and Rehabilitation Clinics of North America
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Court of Dreams.

The Physician and sportsmedicine·2017
Same author

Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2016
Same author

Setting, Structure, and Timing of the Preparticipation Examination: The Wilderness Adventure Consultation.

Wilderness & environmental medicine·2015
Same author

Setting, Structure, and Timing of the Preparticipation Examination: The Wilderness Adventure Consultation.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine·2015
Same author

Mild traumatic brain injury in major and Minor League Baseball players.

The American journal of sports medicine·2015
Same author

Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.

Biomedical microdevices·2015
Same journal

Preface.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Unbound: A Comprehensive Review.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Dual Frontiers Cancer and Palliative Care.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Management Across Special Populations: Pediatrics, Geriatrics, and Pregnancy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Healing from Within: Regenerative Medicine in Pain Therapy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

The Brain in Pain: Exploring Central Pain Disorders.

Physical medicine and rehabilitation clinics of North America·2026
See all related articles

This overview helps clinicians understand performance-enhancing drug risks, covering prohibited substances, exemptions, and adverse effects of doping. It also details how inadvertent anti-doping rule violations can occur for physicians and patients.

Area of Science:

  • Sports Medicine
  • Pharmacology
  • Clinical Toxicology

Background:

  • Performance-enhancing drugs (PEDs) pose significant health risks to athletes.
  • Clinicians require updated information on prohibited substances and their illicit use in sports.

Purpose of the Study:

  • To provide clinicians with a comprehensive understanding of PEDs.
  • To highlight risks associated with PEDs, including megadose and polypharmacy doping.
  • To educate on inadvertent anti-doping rule violations.

Main Methods:

  • Review of prohibited substance lists and therapeutic use exemptions.
  • Analysis of legitimate indications and adverse effects of common PEDs.
  • Examination of doping methods, including stimulants, anabolic steroids, erythropoiesis-stimulating agents, and growth hormone.
Keywords:
Anabolic steroidsBlood dopingDietary supplementsGrowth hormoneNonanalytical positive doping casesSports dopingStimulantsTherapeutic use exemptions

Related Experiment Videos

Main Results:

  • Detailed information on prohibited substances and methods is presented.
  • Adverse effects of PEDs, including high-dose and multiple-drug use, are outlined.
  • Potential pitfalls leading to anti-doping rule violations for healthcare providers and patients are identified.

Conclusions:

  • Clinicians must be aware of PED risks and anti-doping regulations.
  • Understanding legitimate uses and adverse effects is crucial for patient safety.
  • Preventing inadvertent anti-doping violations requires comprehensive knowledge of current guidelines.